Why the study?
The prevalence of atrial fibrillation and diabetes mellitus is rising to epidemic proportions, but the impact of diabetes on the management and outcomes of patients with AF required assessment.
Does diabetes worsen clinical outcomes, quality of life, and healthcare resource utilization in patients with atrial fibrillation?
Population
11,028 patients with AF across 27 European countries
Comparison
Patients with diabetes vs those without diabetes
Design
Prospective observational registry from 250 centres
Follow-up
Median 24 months
Key result
In patients with atrial fibrillation, diabetes was an independent risk factor for major adverse cardiovascular events (HR 1.26; 95% CI 1.04-1.52), all-cause mortality, and cardiovascular mortality.
Authors
Loading...
Supports closer monitoring in diabetic AF patients; leaves open whether glycemic control alters prognosis.
Observational (n=11,028)
Yes
Does diabetes worsen clinical outcomes, quality of life, and healthcare resource utilization in patients with atrial fibrillation?
Hazard Ratio: 1.26 (95% CI 1.04–1.52)
In patients with atrial fibrillation, concomitant diabetes is associated with worse quality of life, higher healthcare resource utilization, and an increased risk of major adverse cardiovascular events and mortality.
Ding et al. (2022) conducted an observational in Atrial fibrillation (n=11,028). Diabetes mellitus vs. No diabetes was evaluated on Major adverse cardiovascular event (MACE) (HR 1.26, 95% CI 1.04-1.52). In patients with atrial fibrillation, diabetes was an independent risk factor for major adverse cardiovascular events (HR 1.26; 95% CI 1.04-1.52), all-cause mortality, and cardiovascular mortality.